Keywords: athena, zanaflex, suffers, setback, usa, neurosciences, stock

Athena's Zanaflex Suffers Setback In USA

Article | 13 March 1995

Print This

Athena Neurosciences' stock took a tumble last week on the news that the US Food and Drug Administration sent the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in